Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00418496
Status:
COMPLETED
Last Update Posted:
2017-02-20
First Post:
2007-01-02
Brief Title:
Interleukin-2 With Sorafenib BAY 43-9006 for Unresectable or Metastatic Clear Cell Renal Carcinoma RCC and Metastatic Melanoma
Sponsor:
Ohio State University Comprehensive Cancer Center
Organization:
Ohio State University Comprehensive Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11-08
Start Date Type:
ACTUAL
Primary Completion Date:
2013-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-10
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-02
First Submit QC Date:
January 3 2007
Study First Post Date:
2007-01-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-17
Last Update Post Date:
2017-02-20
Last Update Post Date Type:
ACTUAL